Pliant Therapeutics Inc (PLRX) Implied Volatility Current

Tracking PLRX implied volatility helps you identify when options premiums on Pliant Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Pliant Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when PLRX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Pliant Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PLRX, tracking metrics like PLRX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PLRX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy.

Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PLRX implied volatility sits today versus where it has been. Our scanner ranks Pliant Therapeutics Inc implied volatility against its historical range, surfaces extremes in PLRX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Pliant Therapeutics Inc IV is rich or cheap — measure it, then act on it.